PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011

Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1177
https://www.valueinhealthjournal.com/article/S1098-3015(12)01242-9/fulltext
Title : PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01242-9&doi=10.1016/j.jval.2012.03.1177
First page : A218
Section Title : Cancer
Open access? : No
Section Order : 697
Categories :
Tags :
Regions :
ViH Article Tags :